Skip to content
Subscriber Only

Movers: Ambac, Genentech, Freddie Mac, United Natural Foods, Intuit

Friday's stocks in the news

Ambac Financial Group (ABK) rises 1.48 to 10.71 after CNBC's Charlie Gasparino reports that significant progress has been made on a bailout plan for ABK that could be announced this Monday or Tuesday.

Genentech (DNA) received FDA approval on Friday for its Avastin drug to treat breast cancer. The Wall Street Journal says this decision "could represent a major shift in standards for assessing the effectiveness of cancer medicines." Avastin is already approved for treating lung and colon cancer.